Related Experiment Video
Updated: Aug 7, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 19, 2013
An unusual gene dosage effect of p27kip1 in a mouse model of prostate cancer
Cory Abate-Shen1, Michael M Shen
1Center for Advanced Biotechnology and Medicine, Department of Medicine, Cancer Institute of New Jersey, UMDNJ-Robert Wood Johnson Medical School, 679 Hoes Lane, Piscataway, NJ 08854, USA. abate@cabm.rutgers.edu
Abstract:
Expression of the p27kip1 cell cycle inhibitor is downregulated in a wide range of carcinomas, yet it is rarely inactivated completely. Our recent studies of a mouse model of prostate carcinogenesis have revealed that cancer progression is enhanced by a two-fold reduction in p27kip1 gene dosage, but is unexpectedly inhibited by further decrease in p27kip1 activity. This paradoxical finding may explain the unusual features of p27kip1 downregulation in human cancer, and also suggests a potential route for therapeutic intervention.
Insights
A two-fold reduction in the p27kip1 cell cycle inhibitor enhances prostate cancer progression in mice. However, further decreases in p27kip1 activity unexpectedly inhibit cancer growth, offering therapeutic insights.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p27kip1 (also known as CDKN1B) cell cycle inhibitor is frequently downregulated in various carcinomas.
- Complete inactivation of p27kip1 is rare in human cancers.
Purpose of the Study:
- To investigate the paradoxical effects of p27kip1 gene dosage reduction on prostate cancer progression using a mouse model.
- To explore the implications of these findings for understanding human cancer and potential therapeutic strategies.
Main Methods:
- Utilized a genetically engineered mouse model of prostate carcinogenesis.
- Manipulated p27kip1 gene dosage and activity to assess effects on tumor progression.
- Analyzed cancer progression in response to varying levels of p27kip1 expression.
Main Results:
- A two-fold reduction in p27kip1 gene dosage significantly enhanced prostate cancer progression.
- Further decreases in p27kip1 activity, beyond the two-fold reduction, unexpectedly inhibited cancer progression.
- Observed a paradoxical dose-dependent effect of p27kip1 on tumor growth.
Conclusions:
- The paradoxical regulation of p27kip1 activity may explain its complex role in human prostate cancer.
- Findings suggest that modulating p27kip1 levels or activity could represent a novel therapeutic approach for cancer treatment.
Related Concept Videos
Pleiotropy
Inhibition of Cdk Activity
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

